Selinixor
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Selinixor, covering 2025-07-20 to 2025-07-20. Get the full timeline:
Most recent: Clinical Trial Update: Combination Regimen of Teniposide, PD-1 Monoclonal Antibody and Selinixor for Patients With Relapsed or Refractory PCNSL [NA]